Agenda
Thursday, December 3, 2026
Welcome Day
Poster Session & Welcome Reception
- 6:00 PM - 8:00 PM
- Curb Conservatory & Hall of Fame Rotunda
Sponsored by: AstraZeneca and Exelixis
Industry attendance for this event is exclusive to only the sponsors of the Poster Session & Welcome Reception
Friday, December 4, 2026
day one
Faculty & Fellows Breakfast
- 7:30 AM - 8:20 AM
- Event Hall
Welcome & Opening Remarks
- 8:30 AM - 8:50 AM
- Event Hall
Chairs:
Alicia Morgans, MD, MPH, FASCO (Harvard Medical School)
Daniel George, MD, FASCO (Duke Cancer Institute)
Alicia Morgans, MD, MPH, FASCO (Harvard Medical School)
Daniel George, MD, FASCO (Duke Cancer Institute)
- SESSION 1
- CMA Theater
The New Frontier of Diagnostics in GU Cancers: How Are They Informing Practice?
Session Chair: Alan Bryce, MD (City of Hope)
- 8:50 AM
ctDNA Guided Treatment Decisions
Stephanie Berg, DO (Harvard Medical School)
- 8:55 AM
Incorporating New Biomarkers
Himisha Beltran, MD (Harvard Medical School)
- 9:00 AM
Artificial Intelligence MD: Is It Ready For Primetime?
Michael Lattanzi, MD (Texas Oncology)
- 9:05 AM
Artificial Intelligence Decision-Making Tools: Advantages and Limitations
Daniel Spratt, MD (University Hospitals Seidman Cancer Center)
- 9:10 AM
Panel Discussion and Q&A
Edward Arrowsmith, MD, MPH (Tennessee Oncology)
Bradley Somer, MD (West Cancer Center & Research Institute)
Bradley Somer, MD (West Cancer Center & Research Institute)
- SESSION 2
- CMA Theater
King Kong vs Godzilla: Antibody Drug Conjugates & Radioligand Therapies
Session Chair: Evan Yu, MD (Fred Hutch Cancer Center)
- 9:40 AM
ADCs in Bladder Cancer
Amanda Nizam, MD (Cleveland Clinic)
- 9:45 AM
Radioligand Therapy in Prostate
Atish Choudhury, MD, PhD (Harvard Medical School)
- 9:50 AM
ADC vs RLT in Kidney
Eric Jonasch, MD (MD Anderson Cancer Center)
- 9:55 AM
Bispecifics vs CAR-T Disruption
Benjamin Garmezy, MD (Sarah Cannon Research Institute)
- 10:00 AM
Panel Discussion and Q&A
Elizabeth Kessler, MD (University of Colorado Health)
Ulka Vaishampayan, MD, FASCO (University of Michigan)
Ulka Vaishampayan, MD, FASCO (University of Michigan)
Networking Break
- 10:30 AM - 11:00 AM
- Grand Foyer
- SESSION 3
- CMA Theater
Multidisciplinary Care of High-Risk Patients in GU Cancers
Session Chair: Ashley Ross, MD, PhD (Northwestern Medicine)
- 11:00 AM
LUGPA Community Perspective Prostate
Benjamin Lowentritt, MD, FACS (Chesapeake Urology Associates)
- 11:05 AM
High-Risk Bladder Cancer
Jason Efstathiou, MD, DPhil, FASTRO, FACRO (Mass General Brigham Cancer Institute)
- 11:10 AM
High-Risk Kidney Cancer
Naomi Haas, MD (University of Pennsylvania)
- 11:15 AM
Nurse Navigation - Corralling the Team/Patient Support
Stacy Walker, FNP-BC (Harvard Medical School)
- 11:20 AM
Panel Discussion and Q&A
Jiaoti Huang, MD, PhD (Duke Cancer Institute)
Vijay Gunuganti, MD (Texas Oncology)
Vijay Gunuganti, MD (Texas Oncology)
Lunch Industry Symposium (Non-CE)
- 12:15 PM - 1:15 PM
- Event Hall
IMFINZI® (durvalumab) + BCG: Expanding Treatment Options in BCG-Naive High-Risk Non–Muscle-Invasive Bladder Cancer
Speaker: Karine Tawagi, MD (University of Illinois at Chicago)
Sponsored by: AstraZeneca
Industry attendance is limited to lunch symposium sponsor only
- SESSION 4
- CMA Theater
Rubber Meets the Road for Real-World Management in GU Cancers - Part I
Session Chair: Elisabeth Heath, MD, FACP (Mayo Clinic)
- 1:30 PM
Alternative Dosing of Systemic Therapies
Pedro Barata, MD, MSc (University Hospitals Seidman Cancer Center)
- 1:35 PM
Treatment Holidays - When Do We Hold Outside of PD?
Michael Harrison, MD (Duke Cancer Institute)
- 1:40 PM
Consolidative Treatments - When Do We Combine Modalities?
Andrew Hahn, MD (MD Anderson Cancer Center)
- 1:45 PM
Remastering or Reboot in Supportive Care
Elizabeth Wulff, MD (University of Kansas Medical Center)
- 1:50 PM
Panel Discussion and Q&A
David Slosky, MD (Tennessee Oncology)
Kristen Nuspl, PA-C (Harvard Medical School)
Kristen Nuspl, PA-C (Harvard Medical School)
- SESSION 5
- CMA Theater
How I Manage Rare Histologies
Session Chair: Robert Dreicer, MD, MS, MACP, FASCO (University of Virginia Health)
- 2:15 PM
Advancements in Small Cell Prostate Cancer
Ana Aparicio, MD (MD Anderson Cancer Center)
- 2:20 PM
Management of Metastatic Chromophobe RCC
Pavlos Msaouel, MD, PhD (MD Anderson Cancer Center)
- 2:25 PM
Management of Adenocarcinoma of the Bladder
Arlene Siefker-Radtke, MD (MD Anderson Cancer Center)
- 2:30 PM
Panel Discussion and Q&A
Darren Feldman, MD (Memorial Sloan Kettering Cancer Center)
Brenda Martone, APRN (Northwestern Medicine)
Jeannie Hoffman-Censits, MD (Johns Hopkins Kimmel Cancer Center)
Brenda Martone, APRN (Northwestern Medicine)
Jeannie Hoffman-Censits, MD (Johns Hopkins Kimmel Cancer Center)
Networking Break
- 3:00 PM - 3:30 PM
- Grand Foyer
- SESSION 6
- CMA Theater
Tools for Tomorrow's Oncologist
Session Chair: Sandy Srinivas, MD (Stanford University Medicine)
- 3:30 PM
Genetic Testing Evolution: Right Test, Right Patient
Benjamin Maughan, MD, PharmD (UT Health San Antonio)
- 3:40 PM
The Evolving PETshop
Scott Tagawa, MD, MS, FACP, FASCO (Weill Cornell Medicine)
- 3:50 PM
EMR: Friend or Foe
Brooke Looney, PharmD, CSP (Vanderbilt University Medical Center)
- 4:00 PM
Focus on Focal Therapy
Mai Anh Huynh, MD, PhD (Mass General Brigham Cancer Institute)
- 4:10 PM
Q&A
- SESSION 7
- CMA Theater
- 4:20 PM
Keynote Presentation (Non-CE)
Alex Sheen
TEDxTalk speaker, author, podcast host, internationally-recognized humanitarian, and Founder of the because I said I would movement.
Saturday, December 5, 2026
day two
Breakfast Symposium (Non-CE)
- 7:30 AM - 8:20 AM
- Event Hall
Women Leaders in GU Cancers
Moderator: Elisabeth Heath, MD, FACP (Mayo Clinic)
Panelists:
Monika Joshi, MD, MRCP (Penn State Cancer Institute)
Arlene Siefker-Radtke, MD (MD Anderson Cancer Center)
Sandy Srinivas, MD (Stanford University Medicine)
Cora Sternberg, MD, FACP (Weill Cornell Medicine)
Monika Joshi, MD, MRCP (Penn State Cancer Institute)
Arlene Siefker-Radtke, MD (MD Anderson Cancer Center)
Sandy Srinivas, MD (Stanford University Medicine)
Cora Sternberg, MD, FACP (Weill Cornell Medicine)
Sponsored by: AstraZeneca
Industry attendance is limited to breakfast symposium sponsor only
Opening Remarks
- 8:30 AM - 8:45 AM
- Event Hall
Chairs:
Alicia Morgans, MD, MPH, FASCO (Harvard Medical School)
Daniel George, MD, FASCO (Duke Cancer Institute)
Alicia Morgans, MD, MPH, FASCO (Harvard Medical School)
Daniel George, MD, FASCO (Duke Cancer Institute)
- SESSION 8
- CMA Theater
The Big Deal about Small Things in GU Cancers
Session Chair: Mark Fleming, MD (Virginia Oncology Associates)
- 8:45 AM
Detection after Primary Local Therapy: Why Not Just Use PSA?
Charles Ryan, MD (Memorial Sloan Kettering Cancer Center)
- 8:50 AM
Microscopic Detection Following Systemic Therapy
- 8:55 AM
High Risk Screening Population
Mutlay Sayan, MD (Harvard Medical School)
- 9:00 AM
Panel Discussion and Q&A
Kristen Scarpato, MD, MPH (Vanderbilt University Medical Center)
Jonathan Leeman, MD (Harvard Medical School)
Jonathan Leeman, MD (Harvard Medical School)
- SESSION 9
- CMA Theater
Strategy and Balance: Finding the Optimal Intensity
Session Chair: Hans Hammers, MD, PhD (UT Southwestern Medical Center)
- 9:30 AM
mProstate: Intensification vs De-intensification
Chandler Park, MD (Norton Healthcare)
- 9:35 AM
Kidney: Oligometastases
Bradley McGregor, MD (Harvard Medical School)
- 9:40 AM
Bladder Directed Therapy or Systemic Treatment Alone
Daniel Sentana Lledo, MD (Harvard Medical School)
- 9:45 AM
Panel Discussion and Q&A
Jeffrey Yorio, MD (Texas Oncology)
David Braun, MD, PhD (Yale Cancer Center)
David Braun, MD, PhD (Yale Cancer Center)
Networking Break
- 10:15 AM - 10:45 AM
- Grand Foyer
- SESSION 10
- CMA Theater
Rubber Meets the Road for Real-World Management in GU Cancers - Part 2
Session Chair: Dana Rathkopf, MD (Memorial Sloan Kettering Cancer Center)
- 10:45 AM
Finding the Right Partner: Kidney
Karine Tawagi, MD (University of Illinois at Chicago)
- 10:50 AM
Finding the Right Partner: New Combinations in Prostate Cancer
Mohammad Atiq, MD, FACP (University of Chicago Medicine)
- 10:55 AM
Finding the Right Partner: New Combinations in Bladder Cancer
Jacqueline Brown, MD (Winship Cancer Institute of Emory University)
- 11:00 AM
Integrative Medicine Approaches
Ting Bao, MD, MS, FSIO (City of Hope)
- 11:05 AM
Panel Discussion and Q&A
Mollie deShazo, MD (University of Alabama at Birmingham)
Vitor Fiorin De Vasconcellos, MD, PhD (University of Iowa)
Vitor Fiorin De Vasconcellos, MD, PhD (University of Iowa)
Lunch Industry Symposium (Non-CE)
- 11:45 AM - 12:45 PM
- Event Hall
- SESSION 11
- CMA Theater
The Evolving Landscape
Session Chair: Daniel Geynisman, MD (Fox Chase Cancer Center)
- 1:00 PM
Prostate
Cora Sternberg, MD, FACP (Weill Cornell Medicine)
- 1:10 PM
Kidney
Tian Zhang, MD, MHS, FASCO (UT Southwestern Medical Center)
- 1:20 PM
Bladder
Guru Sonpavde, MD (AdventHealth Cancer Institute)
- 1:30 PM
Panel Discussion and Q&A
Chad Cherington, MD (Ironwood Cancer & Research Center)
Shalini Moningi, MD (Cleveland Clinic)
Shalini Moningi, MD (Cleveland Clinic)
- SESSION 12
- CMA Theater
Applying the Good News into Everyday Practice
Session Chairs:
Alicia Morgans, MD, MPH, FASCO (Harvard Medical School)
Charles Ryan, MD (Memorial Sloan Kettering Cancer Center)
Alicia Morgans, MD, MPH, FASCO (Harvard Medical School)
Charles Ryan, MD (Memorial Sloan Kettering Cancer Center)
- 1:40 PM
Panel Discussion and Q&A
Monika Joshi, MD, MRCP (Penn State Cancer Institute)
Katy Beckermann, MD, PhD (Tennessee Oncology)
David VanderWeele, MD, PhD (Northwestern Medicine)
Chandler Park, MD (Norton Healthcare)
Katy Beckermann, MD, PhD (Tennessee Oncology)
David VanderWeele, MD, PhD (Northwestern Medicine)
Chandler Park, MD (Norton Healthcare)
- SESSION 13
- CMA Theater
- 2:40 PM
Gameshow Finale!
Presenter: Mark Pomerantz, MD (Harvard Medical School)
- Event Hall
- 3:00 PM
Farewell Reception
Experience Nashville, TN
Come for the education.
Stay for the fun.